Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Czechia
Clinical trial register · Czechia

Clinical Trials in Czechia

Every study on the ClinicalTrials.gov registry that lists a site in Czechia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 1513 matching records held by the registry are in this view. Synced 11 Nov 2026, 03:18 UTC
1513
Studies in scope
all four open statuses
780
Recruiting now
open to new participants
300
Lead sponsors
across recruiting studies
Top sites
Prague 1080 Brno 610 Hradec Králové 323 Olomouc 313 Ostrava 282
Narrow the register
Recruitment status
Phase
Lead sponsor
Novartis Pharmaceuticals69 Charles University, Czech Republic56 AstraZeneca51 Eli Lilly and Company48 Merck Sharp & Dohme LLC47 Janssen Research & Development, LLC46 Sanofi40 AbbVie36 Pfizer36 Bristol-Myers Squibb30 University Hospital Ostrava30 Hoffmann-La Roche29 Amgen20 Takeda20 Boehringer Ingelheim18 General University Hospital, Prague17 Masaryk University16 Novo Nordisk A/S16 Institute for Clinical and Experimental Medicine14 argenx12 University Hospital Hradec Kralove12 GlaxoSmithKline11 Bayer11 Brno University Hospital11 St. Anne's University Hospital Brno, Czech Republic11 Genmab11 Masaryk Memorial Cancer Institute11 The Institute of Molecular and Translational Medicine, Czech Republic10 Incyte Corporation10 University Hospital Olomouc9 Palacky University9 UCB Biopharma SRL9 Alexion Pharmaceuticals, Inc.8 Biogen8 Celgene8 Daiichi Sankyo8 University Hospital Pilsen8 BeOne Medicines8 University Hospital, Motol8 Boston Scientific Corporation8 Faculty Hospital Kralovske Vinohrady7 Institute of Health Information and Statistics of the Czech Republic7 Masarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s.7 Ipsen7 Loxo Oncology, Inc.7 Gilead Sciences7 Exelixis7 Abbott Medical Devices7 European Organisation for Research and Treatment of Cancer - EORTC6 Regeneron Pharmaceuticals6 University of Alberta6 Czech Technical University in Prague5 European Myeloma Network B.V.5 Acerta Pharma BV5 Tomas Bata Hospital, Czech Republic5 Biotronik SE & Co. KG5 University of Ostrava4 Astellas Pharma Global Development, Inc.4 Swedish Orphan Biovitrum4 Immunovant Sciences GmbH4 Alnylam Pharmaceuticals4 Genzyme, a Sanofi Company4 ACADIA Pharmaceuticals Inc.4 Seagen, a wholly owned subsidiary of Pfizer4 Medtronic4 Charite University, Berlin, Germany4 Nemocnice AGEL Trinec-Podlesi a.s.4 National Institute of Mental Health, Czech Republic4 Karuna Therapeutics, Inc., a Bristol Myers Squibb company3 Copenhagen University Hospital, Rigshospitalet3 Octapharma3 Zenas BioPharma (USA), LLC3 Medtronic Cardiac Ablation Solutions3 Ascentage Pharma Group Inc.3 Astria Therapeutics, Inc.3 Insel Gruppe AG, University Hospital Bern3 Intra-Cellular Therapies, Inc.3 Xenon Pharmaceuticals Inc.3 Vertex Pharmaceuticals Incorporated3 Military University Hospital, Prague3 AOP Orphan Pharmaceuticals AG3 Mirati Therapeutics Inc.3 Viatris Innovation GmbH3 MoonLake Immunotherapeutics AG3 Otsuka Pharmaceutical Development & Commercialization, Inc.3 CSL Behring3 EMD Serono Research & Development Institute, Inc.3 Institute of Hematology and Blood Transfusion, Czech Republic3 ADARx Pharmaceuticals, Inc.3 BioNTech SE3 Tesaro, Inc.3 BTL Industries Ltd.3 Abivax S.A.3 Na Homolce Hospital3 Leiden University Medical Center3 Genentech, Inc.3 Gustave Roussy, Cancer Campus, Grand Paris3 Aesculap AG3 Karyopharm Therapeutics Inc3 Spyre Therapeutics, Inc.3 Agios Pharmaceuticals, Inc.3 Aragon Pharmaceuticals, Inc.3 Arrowhead Pharmaceuticals3 Denali Therapeutics Inc.3 Cogent Biosciences, Inc.2 EyeBiotech Ltd.2 Chugai Pharmaceutical2 Glycomine, Inc.2 Pulse Biosciences, Inc.2 CardioFocus2 VectivBio AG2 ADC Therapeutics S.A.2 OrbusNeich2 Celcuity Inc2 Neurocrine Biosciences2 Eisai Inc.2 Kailera2 Upstream Bio Inc.2 Sun Pharmaceutical Industries Limited2 Bluefin Biomedicine, Inc.2 Kardium Inc.2 Olema Pharmaceuticals, Inc.2 Universitätsklinikum Hamburg-Eppendorf2 Merz Therapeutics GmbH2 Alfasigma S.p.A.2 Institut de Recherches Internationales Servier2 NovoCure GmbH2 Pharming Technologies B.V.2 icometrix2 Duke University2 Insmed Incorporated2 Heidelberg University2 Kartos Therapeutics, Inc.2 Anthos Therapeutics, Inc.2 Thomayer University Hospital2 University Hospital Muenster2 University of Birmingham2 University College Dublin2 NeuroDerm Ltd.2 Arcus Biosciences, Inc.2 Biohaven Therapeutics Ltd.2 Institute of Spa and Balneology, public research institution2 Ferring Pharmaceuticals2 The Central and Eastern European Gynecologic Oncology Group2 Juno Therapeutics, Inc., a Bristol-Myers Squibb Company2 Weill Medical College of Cornell University2 Teva Branded Pharmaceutical Products R&D LLC2 Ascletis Pharma (China) Co., Limited2 Ionis Pharmaceuticals, Inc.2 NewAmsterdam Pharma2 Alkermes, Inc.2 Apellis Pharmaceuticals, Inc.2 Seaport Therapeutics2 European Society of Cardiology2 EyePoint Pharmaceuticals, Inc.2 Stichting European Myeloma Network2 Apogee Therapeutics, Inc.2 Czech Lymphoma Study Group2 Celldex Therapeutics2 Mirum Pharmaceuticals, Inc.2 Revolution Medicines, Inc.2 Colorado Prevention Center2 Niguarda Hospital2 Fresenius Medical Care Deutschland GmbH2 Janssen-Cilag Ltd.2 Stimvia s.r.o.1 Morten H. Bestle1 Ever Neuro Pharma GmbH1 Intellia Therapeutics1 Dimerix Bioscience Pty Ltd1 VDI Technologies1 Guerbet1 Xcovery Holdings, Inc.1 Immunocore Ltd1 University in Zielona Góra1 Pharmacyclics Switzerland GmbH1 University Hospital, Bonn1 Stemline Therapeutics, Inc.1 Biohaven Pharmaceuticals, Inc.1 Tenax Therapeutics, Inc.1 Azienda Unita Sanitaria Locale di Piacenza1 University of Massachusetts, Worcester1 Associazione Italiana Ematologia Oncologia Pediatrica1 Pregnolia AG1 PedNet Haemophilia Research Foundation1 Blueprint Medicines Corporation1 Indiana University1 Kymera Therapeutics, Inc.1 MEBSTER1 Javier P. Gisbert1 UMC Utrecht1 Hamlet Pharma AB1 Gemini Eye Clinic1 Womed1 Alumis Inc1 IntraBio Inc1 Marketa Bonaventurova1 Axon Therapies, Inc.1 Janssen Biotech, Inc.1 Friedreich's Ataxia Research Alliance1 Rigel Pharmaceuticals1 Philipp Dutkowski1 Pulmovant, Inc.1 Alentis Therapeutics AG1 King's College London1 AtriCure, Inc.1 Orchestra BioMed, Inc1 The University of Texas Health Science Center, Houston1 Nektar Therapeutics1 SOTIO Biotech AG1 M.A. Med Alliance S.A.1 IRCCS San Raffaele Roma1 X4 Pharmaceuticals1 Summit Therapeutics1 Kura Oncology, Inc.1 LinkoCare Life Sciences AB1 Kite, A Gilead Company1 Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau1 Stichting International Registry for Alzheimer's Disease and other Dementias Foundation1 Dompé Farmaceutici S.p.A1 Syndax Pharmaceuticals1 Rare Thyroid Therapeutics International AB1 Kyowa Kirin Pharmaceutical Development Ltd1 RHEACELL GmbH & Co. KG1 Memorial Sloan Kettering Cancer Center1 Gossamer Bio USA, Inc.1 Dianthus Therapeutics1 European Clinical Research Alliance for Infectious Diseases (ECRAID)1 Cutting Edge SAS1 Zai Lab (Shanghai) Co., Ltd.1 ALPFA Medical1 Britannia Pharmaceuticals Ltd.1 Annexon, Inc.1 GT Metabolic Solutions, Inc.1 Menarini Group1 CanariaBio Inc.1 Isabelle Herter-Aeberli1 GLSMED Learning Health S.A.1 Taiho Oncology, Inc.1 Almirall, S.A.1 BackBeat Medical Inc1 Eidos Therapeutics, a BridgeBio company1 Rede Optimus Hospitalar SA1 ONL Therapeutics1 Inventiva Pharma1 Universitaire Ziekenhuizen KU Leuven1 University Hospital, Akershus1 IO Biotech1 Eikon Therapeutics1 North Eastern German Society of Gynaecological Oncology1 Draig Therapeutics Ltd1 HUYABIO International, LLC.1 Nemocnice Kolín1 Masarykova Univerzita1 Philippe ROUSSELOT1 European Association of Urology Research Foundation1 Lipidica, a.s.1 Mitera Hospital1 CoreMap Inc.1 Australasian Gastro-Intestinal Trials Group1 Pierre Fabre Medicament1 Grifols Therapeutics LLC1 Philips Clinical & Medical Affairs Global1 Myopowers Medical Technologies France SAS1 Chiesi Farmaceutici S.p.A.1 Jan Žatecký1 Janssen Scientific Affairs, LLC1 EPC Education s.r.o.1 LUMA Vision Ltd.1 St. Anna Kinderkrebsforschung1 Epics Therapeutics1 Javelin Medical1 iTeos Therapeutics1 CeleCor Therapeutics1 Actelion1 Abcentra1 VDyne, Inc.1 JaxBio Ltd1 ITM Solucin GmbH1 University of California, Davis1 SystImmune Inc.1 Baxalta now part of Shire1 University of Zurich1 Lexeo Therapeutics1 Julius Clinical1 Field Medical1 Ultragenyx Pharmaceutical Inc1 Dizal Pharmaceuticals1 Ancora Heart, Inc.1 LMU Klinikum1 Applied Therapeutics, Inc.1 Curis, Inc.1 SpliSense Ltd.1 Tanabe Pharma America, Inc.1 Deciphera Pharmaceuticals, LLC1 Region Örebro County1 Carl Zeiss Meditec AG1 PhenoNet, Inc.1 St George's, University of London1 European Foundation for Study of Chronic Liver Failure1 Hansa Biopharma AB1 Perfect Lens, LLC1 Sitala Bio LTD1 Abiomed Inc.1 Martin Harazim1 Cerevance1 Belite Bio, Inc1 Lukas Vanek1 College of Physical Education and Sport PALESTRA1 Sanofi Pasteur, a Sanofi Company1 Institut Claudius Regaud1 Dr. Yaroslav Winter1 Alimentiv Inc.1 INNODIA iVZW1 UNICANCER1 Martin Schrappe1 Primex ehf1 Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany1 TG Therapeutics, Inc.1 Vanda Pharmaceuticals1 Western Sydney Local Health District1 Institut Curie1 Research Maatschap Cardiologen Rotterdam Zuid1 Princess Maxima Center for Pediatric Oncology1 Fondazione IRCCS Istituto Nazionale dei Tumori, Milano1 University of Cambridge1 Cytokinetics1 Nikola Janovska1 COMPASS Pathways1 Zuyderland Medisch Centrum1 ENDOPLY1 MapLight Therapeutics1 medac GmbH1 Centre Hospitalier Universitaire de Liege1 Jiangsu HengRui Medicine Co., Ltd.1 Nuvalent Inc.1 pharmaand GmbH1 Stichting Hemato-Oncologie voor Volwassenen Nederland1 International Extranodal Lymphoma Study Group (IELSG)1 4TEEN4 Pharmaceuticals GmbH1 United Therapeutics1 Servier Bio-Innovation LLC1 Relay Therapeutics, Inc.1 Erasca, Inc.1 Cortex1 Centre Leon Berard1 Alpine Immune Sciences Inc, A Subsidiary of Vertex1 MRM Health NV1 AVEO Pharmaceuticals, Inc.1 Poitiers University Hospital1 Martina Lojova1 Alleviant Medical, Inc.1 Cybin IRL Limited1 PedAL BCU, LLC1 Marie Lulková1 Corvia Medical1 Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS1 Digma Medical Ltd.1 Interni hematologicka klinika FNKV1 SecuraBio1 Arga Medtech SA1 Jazz Pharmaceuticals1 The Hospital for Sick Children1 Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)1 Vedanta Biosciences, Inc.1 Delcath Systems Inc.1 Foundry Innovation & Research 1, Limited (FIRE1)1 Bambino Gesù Hospital and Research Institute1 Eagle Pharmaceuticals, Inc.1 FineHeart1 Bellus Health Inc. - a GSK company1 BeiGene1 Insud Pharma1 University Hospital Tuebingen1 St. Justine's Hospital1 Definium Therapeutics US, Inc.1 Children's Oncology Group1 Italfarmaco1 Vladimíra Dostálová1 Medtronic Cardiac Rhythm and Heart Failure1 University Hospital, Geneva1 Manuel Monreal1 Vojtech Melenovsky, MD, PhD1 Provention Bio, a Sanofi Company1 Palisade Bio1 AlgoTherapeutix1 KARDI AI Technologies s.r.o.1 Redx Pharma Ltd1 Elena Gurkova1 IDEAYA Biosciences1 Cellectar Biosciences, Inc.1 Santhera Pharmaceuticals1 Protagonist Therapeutics, Inc.1 Generate Biomedicines1 Imagine Institute1 Motol and Homolka University Hospital1 University Hospital Freiburg1 Stealth BioTherapeutics Inc.1 Johnson & Johnson Enterprise Innovation Inc.1 Day One Biopharmaceuticals, Inc.1 Shanghai Henlius Biotech1 University of Regensburg1 National and Kapodistrian University of Athens1 Aura Biosciences1 Gesynta Pharma AB1 Philip Morris Products S.A.1 KU Leuven1 CIATRIX, INC.1 Silesian Hospital in Opava1 Vor Biopharma1 Odyssey Therapeutics, Inc.1 Prilenia1 AriBio Co., Ltd.1 Instituto Portugues Oncologia de Lisboa Francisco Gentil1 Bicara Therapeutics1 Kedrion S.p.A.1 Centre Hospitalier Universitaire de Besancon1 Calcilytix Therapeutics, Inc., a BridgeBio company1 CatalYm GmbH1 Orchid Pharma Europe GmbH1 BioAegis Therapeutics Inc.1 Bausch & Lomb GmbH1 Faron Pharmaceuticals Ltd1 Sirius Therapeutics Co., Ltd.1 Moleculin Biotech, Inc.1 Miltenyi Biomedicine GmbH1 Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico1 Append Medical Ltd.1 Xentria, Inc.1 Luye Pharma Group Ltd.1 eleva GmbH1 Innovacell GmbH1 Ono Pharmaceutical Co., Ltd.1 Exciva GmbH1 BioVentrix1 Medical University of Vienna1 Avalyn Pharma Inc.1 University Medical Center Groningen1 Geron Corporation1 Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)1 Oslo University Hospital1 IRCCS San Raffaele1 Philipp Homan1 Pharvaris Netherlands B.V.1 Janssen Pharmaceutica N.V., Belgium1 Apollo Therapeutics Ltd1 NS Pharma, Inc.1 International CTEPH Association1 MedSIR1 KeyBioscience AG1 Genexine, Inc.1 Emergency Medical Service, Prague1 Priovant Therapeutics, Inc.1 Santen SAS1 BioCryst Pharmaceuticals1 University Hospital, Gasthuisberg1 Merz Pharmaceuticals GmbH1 Pomeranian Medical University Szczecin1 Triveni Bio1 Lexicon Pharmaceuticals1 Biotest1
Site location
Prague1080 Brno610 Hradec Králové323 Olomouc313 Ostrava282 Pilsen117 Pardubice92 České Budějovice61 Zlín47 Nový Jičín45 Uherské Hradiště38 Liberec36 Náchod33 Ústí nad Labem33 Ostrava - Poruba32 Ostrava-Poruba32 Brandýs nad Labem30 Jihlava29 Teplice26 Hořovice24 Slaný17 Hodonín16 Kladno15 Hlučín14 Choceň14 Jindřichův Hradec14 Český Krumlov14 Rychnov nad Kněžnou13 Chlumec nad Cidlinou13 Broumov13 Havířov13 Benešov12 Krnov12 Třinec10 Mladá Boleslav9 Opava8 Klecany8 Kutná Hora7 Kralupy nad Vltavou7 Varnsdorf7 Jaroměř7 Louny7 Mariánské Lázně7 Kolín6 Havlíčkův Brod6 Jablonec nad Nisou6 Příbram6 Klatovy6 Ostrava-Vitkovice5 Bruntál5 Chomutov5 Ostrava - Vitkovice5 Frýdek-Místek5 Jílové u Prahy5 Ostrava Poruba5 Humpolec5 Hradec Kralova5 Nový Hradec Králové5 Karvina Frystat5 Praha 4 - Krc4 Karlovy Vary4 Brno-Bohunice4 Chrudim4 Litovel4 Břeclav4 Holešov4 Brandýs nad Labem-Stará Boleslav4 Tábor4 Brno-Židenice4 Přerov4 Trutnov4 Lovosice4 Kroměříž4 Poruba4 Plzen Bory4 Hradec Králove4 Nový Jiín3 Plzen Bolevec3 Bílovec3 Ostrava-poruba3 Česká Lípa3 Sokolov3 Miroslav3 Praha Klanovice3 Jilemnice3 Ledeč nad Sázavou3 Pardubice V3 Plzen - Lochotin3 New Town3 Dolní Břežany3 Kyjov3 Nymburk2 Beroun2 Havirov - Mesto2 Ostrava-Vítkovice2 Říčany2 Bohnice2 Praha 8 - Liben2 PLZE2 Motol2 Praha 5 - Motol2 Praha 8 - Libeň2 Poděbrady2 Nové Město na Moravě2 V Uvalu 842 Vodňany2 Chrudim III2 Plzen-bory2 Bílina2 Roudnice nad Labem2 Česká Třebová2 Králová2 Rokycany2 Strakonice2 Studénka2 Vsetín2 Benesov U Prahy2 Praha 4-Krc2 Nový Jicin2 Praha 1- Mala Strana2 Janske Lazne1 Ostrava - Vítkovice1 Hradec Kralove1 Jind?ich?v Hradec1 Czechia1 Plze?1 Kladruby1 Lázně Bělohrad1 Protivín1 Brno-Královo Pole1 Severomoravsky KRAJ1 Vinohrady1 Praha 8-Liben1 Multiple Locations1 Praha 8 Liben1 Brno-Vinohrady1 Vyškov1 Vítkovice1 Plzen - Bory1 Praha 2 - Nové Město1 Milovice1 Jinočany1 Ostrava- Vitkovice1 Jindichv Hradec1 Boskovice1 Měšice1 Františkovy Lázně1 Most1 Jesenice1 Praha 9 - Klánovice1 Blansko1 Borovany1 Brněnec1 Bystřice pod Hostýnem1 Čelákovice1 Česká Kamenice1 Pragues1 Brno-Zidonice1 Lomnice1 Mohelnice1 Rudná1 Velké Popovice1 Nová Ves pod Pleší1 Bedihošť1 Nový Jicín1 Phaha 51 Praha 8- Liben1 Pardubičky1 Praha 13-stodulky1 Děčín1 Praha 2 Nove Mesto1 Benátky nad Jizerou1 Havirov-Podlesi1 Bohuslavice1 Svitavy1 Prague 8 - Liben1 Moravská Ostrava1 Liberec11 Štětí1 Čáslav1 Brno-střed1 Hradec1 Znojmo1 Písek1 Jihlavska1 Prague (Praha)1 Srobarova C1 Habry1 Praha 9 - Klanovice1 Hranice1 Plzen-Bory1 Předměstí1 Sternberk1 Vestec1 Smiřice1 Ústní Nad Labem1 Plzen - Lochotín1 Pribram VIII1 Zizkova1 Pelhřimov1 Slovany1 Vysoké Mýto1 Praha1 Plzen-Lochotin1 Šumperk1 Polička1 Hostivice1 Brandys Nad Lebem1 Hradiště1 Jindrichuv Hradec III1 Police nad Metují1 Třebíč1 Ostrova1 Brno - Sever1 Plzeň 31
All 215 locations
Target enrolment
to

Trials in this register

1513 of 1513 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Czechia
Start
By invitation
Additive Effects of Interoceptive Training to Physiotherapy in Functional Movement Disorders (interoPTfmd)
NCT06792760Functional Neurological Disorder, Functional Movement Disorder
Charles University, Czech Republic
Not applicable
80
Prague
2025-04-01
Not yet open
Masaryk University
Observational
150
Brno
2025-04-01
Not yet open
Point-of-Care Ultrasound in Chronic Heart Failure
NCT06887179Cardiovascular Diseases
Masaryk University
Not applicable
112
Brno
2025-04-01
Recruiting
Evaluation of Catching Skills in Preschoolers With Motor Difficulties
NCT07028762Development Coordination Disorder, Motor Disabilities
Masaryk University
Observational
40
Pardubice
2025-03-31
Recruiting
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Observational
683
Prague
2025-03-31
Recruiting
Eli Lilly and Company
Phase 3
700
Ostrava, Prague
2025-03-27
Recruiting
Bayer
Phase 1/2
450
Olomouc, Brno
2025-03-21
Active, closed
Novartis Pharmaceuticals
Phase 3
565
Karlovy Vary, Plzen Bolevec, Prague
2025-03-20
Active, closed
Astria Therapeutics, Inc.
Phase 3
157
Hradec Králové, Prague
2025-03-20
Recruiting
Daiichi Sankyo
Phase 3
582
Ostrava-Poruba, Prague
2025-03-19
Recruiting
VDI Technologies
Observational
360
Brno, Prague
2025-03-18
Recruiting
AstraZeneca
Phase 3
990
Brandýs nad Labem, Brno, Jindřichův Hradec, Lovosice, Pilsen, Prague, Teplice, Varnsdorf
2025-03-18
Recruiting
Hoffmann-La Roche
Phase 3
600
Brno, České Budějovice, Hradec Králové
2025-03-17
Active, closed
Amgen
Phase 3
1,105
Brno, Ostrava, Pardubice, Prague, Pribram VIII
2025-03-17
Recruiting
Charles University, Czech Republic
Not applicable
25
Prague
2025-03-17
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,000
Ostrava - Poruba, Prague, Brno, Olomouc
2025-03-16
Recruiting
Impact of Delivery Method Elite Athletes.
NCT06803979Delivery, Performance, Caesarean Section, Pregnancy
Faculty Hospital Kralovske Vinohrady
Observational
500
Prague
2025-03-16
Not yet open
Neonatal Oximeter Bias Study
NCT06817850Neonatal Respiratory Distress, Oxygenation
Czech Technical University in Prague
Observational
40
Prague
2025-03-15
Active, closed
EucaLimus Post-Market Registry
NCT06621524Coronary Arterioscleroses
OrbusNeich
Observational
251
Liberec, Prague
2025-03-14
Recruiting
AstraZeneca
Phase 3
11,300
Benešov, Brandýs nad Labem, Brno, Chlumec nad Cidlinou, Hodonín, Humpolec, Jaroměř, Jílové u Prahy
2025-03-14
Recruiting
Bristol-Myers Squibb
Phase 3
60
Olomouc, Prague
2025-03-13
Active, closed
Celgene
Phase 3
960
Brno, Hradec Králové, Olomouc, Prague
2025-03-13
Active, closed
Amgen
Phase 3
3,853
Brandýs nad Labem, Brno, Havířov, Olomouc, Ostrava, Prague
2025-03-12
Recruiting
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Phase 3
440
Brno, Hradec Králové, Ostrava, Prague
2025-03-12
Recruiting
Moleculin Biotech, Inc.
Phase 2/3
312
Hradec Králové
2025-03-12
Recruiting
Evaluation of the Use of Synthetic Glue for Mesh Fixation in Laparoscopic Sacrocolpopexy
NCT06872983Apical Prolapse, Sacrocolpopexy, Glue Fixation
Brno University Hospital
Not applicable
40
Brno
2025-03-11
Recruiting
Early Detection of CTEPH in Patients After APE
NCT06865326Chronic Pulmonary Thromboembolism
Institute of Health Information and Statistics of the Czech Republic
Observational
500
Brno, Havlíčkův Brod, Hradec Králové, Jihlava, Náchod, Olomouc, Ostrava, Pardubice
2025-03-07
Active, closed
A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer
NCT06521567Melanoma, Hodgkin Lymphoma, High and Low Grade Glioma, Glioblastoma Multiforme (GBM)
DrugsCobolimab·Dostarlimab
GlaxoSmithKline
Phase 1/2
83
Brno, Phaha 5
2025-03-06
Recruiting
Vanda Pharmaceuticals
Phase 3
500
Brno, Pilsen, Poruba, Prague
2025-03-03
Recruiting
AstraZeneca
Phase 3
5,000
Brandýs nad Labem, Frýdek-Místek, Jilemnice, Krnov, Mladá Boleslav, Náchod, Olomouc, Pilsen
2025-03-03
Recruiting
Takeda
Phase 3
1,088
Brno, Hlučín, Prague, Uherské Hradiště, Ostrava, Zlín, Pardubice
2025-03-03
Recruiting
Strength-Endurance Circuit Training in Parkinson's Disease
NCT06893055Parkinson Disease, Idiopathic
General University Hospital, Prague
Not applicable
90
Prague
2025-03-03
By invitation
Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0
NCT06823115Acute Kidney Injury, Fluid Overload, Prematurity Complications, Risk Factors
Indiana University
Observational
8,000
Prague
2025-03-01
Not yet open
Charles University, Czech Republic
Observational
120
Prague
2025-03-01
By invitation
AR-Based Motor Rehabilitation for Children With CP
NCT07664878Cerebral Palsy (CP), Augmented Reality Exercise Program
College of Physical Education and Sport PALESTRA
Not applicable
40
Prague
2025-03-01
Recruiting
Incyte Corporation
Phase 3
600
Ostrava-poruba, Prague, Praha 13-stodulky
2025-02-28
Recruiting
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Phase 3
339
Brno, Hradec Králové, Olomouc, Ostrava, Pilsen, Prague
2025-02-27
Recruiting
Daiichi Sankyo
Phase 3
726
Brno, Hradec Králové, Olomouc, Prague
2025-02-27
Recruiting
Bristol-Myers Squibb
Phase 3
530
Brno, Ostrava, Prague, Olomouc
2025-02-25
Recruiting
Chronic Kidney Disease Screening
NCT07153432Chronic Kidney Diseases
Institute for Clinical and Experimental Medicine
Observational
3,000
Prague
2025-02-24
Active, closed
Janssen Research & Development, LLC
Phase 3
552
Brno, Brno-Židenice, Břeclav, Hlučín, Karvina Frystat, Ostrava, Prague, Uherské Hradiště
2025-02-21
Recruiting
Menarini Group
Phase 2
44
Ostrava, Prague
2025-02-18
Recruiting
General University Hospital, Prague
Observational
100
Prague
2025-02-18
Recruiting
Feasibility Study of the FARAFLEX Mapping and PFA System
NCT06510556Atrial Fibrillation, Persistent Atrial Fibrillation, Paroxysmal AF
Boston Scientific Corporation
Not applicable
250
Prague
2025-02-17
Active, closed
AbbVie
Phase 3
468
Brno, Pilsen, Prague, Hradec Králové, Olomouc
2025-02-10
Active, closed
GlaxoSmithKline
Phase 2
307
Brandýs nad Labem, Mladá Boleslav, Teplice
2025-02-10
Not yet open
Charles University, Czech Republic
Observational
39
Prague
2025-02-09
By invitation
ALPFA Medical
Not applicable
100
Brno, Hradec Králové
2025-02-07
Active, closed
Genmab
Phase 3
584
Prague, Brno, Hradec Králové, Nový Jičín
2025-02-07
Recruiting
IRCCS San Raffaele Roma
Not applicable
130
Kladruby, Lázně Bělohrad, Olomouc, Prague
2025-02-06
Active, closed
Sanofi
Phase 3
216
Hradec Králové, Pardubice, Pilsen, Prague
2025-02-06
Active, closed
A Real-World Study to Gain Clinical Insights Into Faricimab (FaReal Study)
NCT06680817Neovascular Age-related Macular Degeneration, Diabetic Macular Edema
DrugsVabysmo·Faricimab
Hoffmann-La Roche
Observational
875
Liberec, Mladá Boleslav, Olomouc, Ostrava, Prague
2025-02-05
Recruiting
Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure
NCT06651970Chronic Lymphocytic Leukaemia, Moderate to Severe Cardiac Impairment
DrugAcalabrutinib
AstraZeneca
Phase 4
60
Brno, Hradec Králové, Prague
2025-02-04
Active, closed
NovoCure GmbH
Phase 3
741
Prague
2025-02-03
Recruiting
Prevention of CIPN Using Compressive Therapy
NCT06823440CIPN in Adjuvant Breast Cancer Patients
Martina Lojova
Not applicable
100
Brno
2025-02-01
Recruiting
Charles University, Czech Republic
Observational
300
Prague
2025-02-01
Recruiting
AbbVie
Observational
1,200
Ostrava, Pilsen
2025-01-31
Recruiting
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
NCT06564038Chronic Lymphocytic Leukaemia, Small Lymphocytic Lymphoma, Mantle-cell Lymphoma, Large B-cell Lymphoma
DrugsSurovatamig·Acalabrutinib·Vincristine·Doxorubicin
AstraZeneca
Phase 1/2
408
Ostrava - Poruba, Prague, Praha 2 - Nové Město
2025-01-30
Active, closed
Definium Therapeutics US, Inc.
Phase 3
245
Pilsen, Prague
2025-01-29
Recruiting
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
NCT06788990Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma
DrugsFicerafusp alfa·Keytruda·Pembrolizumab
Bicara Therapeutics
Phase 2/3
650
Hradec Králové, Prague
2025-01-28
Recruiting
Efficacy and Safety of KBP-336 in Obese Individuals with Osteoarthritis
NCT06833749Osteoarthritis in the Knee, Obesity
KeyBioscience AG
Phase 2
600
Brno, Hlučín, Hradiště, Pardubice, Prague
2025-01-28
Recruiting
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
NCT06767683Narcolepsy Type 1, Narcolepsy Type 2, Idiopathic Hypersomnia
DrugALKS 2680
Alkermes, Inc.
Phase 2/3
786
Prague
2025-01-27
Recruiting
Ascentage Pharma Group Inc.
Phase 3
490
Brno, Hradec Králové, Ostrava, Prague
2025-01-22
By invitation
Training of Relaxation Breathing in Virtual Reality Using Biofeedback: Comparison Study
NCT07064629Relaxation, Anxiety Disorders, Biofeedback Training
National Institute of Mental Health, Czech Republic
Not applicable
30
Klecany
2025-01-21
Recruiting
Rapid Prehospital ACcess to ECPR in Prague
NCT06789978Out of Hospital Cardiac Arrest, Extracorporeal Cardiopulmonary Resuscitation
General University Hospital, Prague
Not applicable
20
Prague
2025-01-20
Recruiting
Na Homolce Hospital
Observational
150
Prague
2025-01-15
Active, closed
Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)
NCT06700343Relapsing-remitting Multiple Sclerosis (RRMS)
DrugOcrelizumab
Amgen
Phase 3
152
Brno, Hradec Králové, Jihlava, Teplice
2025-01-13
Recruiting
A Prospective Observational Study of Video Laryngoscopy Versus Direct Laryngoscopy for Insertion of a Thin Endotracheal Catheter for Surfactant Administration in Newborn Infants
NCT06758492Respiratory Distress Syndrome (Neonatal), Respiratory Distress Syndrome (RDS), Video Laryngoscopy, Surfactant
University College Dublin
Observational
600
Brno, Prague
2025-01-13
Recruiting
A Stepped Wedge Cluster Randomised Trial Of Video Versus Direct Laryngoscopy For Intubation Of Newborn Infants
NCT06757543Intubation, Intubation Complications, Infant, Newborn, Infant Respiratory Distress Syndrome
University College Dublin
Not applicable
840
Brno, Prague
2025-01-13
Recruiting
GlaxoSmithKline
Phase 3
1,840
Jindřichův Hradec, Jinočany, Ostrava, Prague
2025-01-10
Active, closed
Immunovant Sciences GmbH
Phase 2
120
Brno, Ostrava, Praha 2 Nove Mesto, Uherské Hradiště, Zlín
2025-01-10
Active, closed
Janssen Research & Development, LLC
Phase 3
813
Brno, Břeclav, Hlučín, Ostrava, Prague, Uherské Hradiště, Zlín
2025-01-09
Recruiting
ENDOPLY
Not applicable
10
Brno
2025-01-09
Recruiting
Radiologic Features of Rheumatoid Arthritis Interstitial Lung Disease at Chest High Resolution Computed Tomography
NCT07174102Reumatoid Arthritis, Interstitial Lung Disease Due to Systemic Disease (Disorder), Idiopathic Pulmonary Fibrosis (IPF), Connective Tissue Disease (CTD)
Azienda Unita Sanitaria Locale di Piacenza
Observational
500
Prague
2025-01-08
Active, closed
Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis
NCT06846541Plaque Psoriasis, Psoriasis (PsO), Psoriasis, Moderate Psoriasis
Alumis Inc
Phase 3
1,680
Náchod, Ostrava, Prague, Brno, Kutná Hora, Nový Jičín, Olomouc, Pardubice
2025-01-08
Active, closed
Pfizer
Phase 3
1,035
Brno, Prague, Nový Jičín
2025-01-06
Recruiting
Loxo Oncology, Inc.
Phase 2
249
Brno, Hradec Králové, Prague
2025-01-03
Recruiting
Takeda
Phase 3
396
České Budějovice, Hradec Králové, Prague
2025-01-02
By invitation
Gemini Eye Clinic
Observational
100
Zlín
2025-01-01
By invitation
Hearing Screening in Adults Over 50 Years Old
NCT06894927Hearing Loss, Bilateral Sensorineural, Progressive, Hearing Loss, Bilateral (Causes Other Than Tumors), Hearing Loss, Bilateral or Unilateral, Presbyacusis
University Hospital Hradec Kralove
Not applicable
330
Hradec Králové, Pardubice
2025-01-01
Recruiting
Socket Preservation Using Autogenous Dentin
NCT07608289Tooth Extraction Site Healing
University of Ostrava
Not applicable
80
Ostrava
2025-01-01
Recruiting
Charles University, Czech Republic
Observational
50
Prague
2025-01-01
Recruiting
St. Anne's University Hospital Brno, Czech Republic
Phase 2
112
Brno, Olomouc, Ostrava, Ústí nad Labem
2025-01-01
Recruiting
University Hospital Hradec Kralove
Observational
30
Hradec Králové
2025-01-01
Not yet open
Intra-abdominal Hypertension and Abdominal Compartment Syndrome in Patients After Pancreatic Procedures.
NCT06672601Intra Abdominal Pressure, Abdominal Compartment Syndrome, Pancreatic Surgery, Pancreatic Fistula After Pancreaticoduodenectomy
Charles University, Czech Republic
Observational
150
Prague
2025-01-01
Active, closed
Boehringer Ingelheim
Phase 2
90
Olomouc
2024-12-30
Recruiting
Santen SAS
Phase 3
234
Pardubice, Pilsen, Prague
2024-12-30
Active, closed
RHEACELL GmbH & Co. KG
Phase 3
250
Multiple Locations
2024-12-26
Active, closed
Amgen
Phase 2
61
Brno, Olomouc, Prague
2024-12-26
Recruiting
Sanofi
Phase 2
84
Olomouc, Prague
2024-12-19
Active, closed
argenx
Phase 3
154
Brno, Hradec Králové, Prague
2024-12-18
Recruiting
GlaxoSmithKline
Phase 3
520
Ostrava, Prague
2024-12-16
Active, closed
Arcus Biosciences, Inc.
Phase 3
610
Brno, Nový Jičín, Prague
2024-12-13
Recruiting
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
NCT06526195Heart Failure, Heart Diseases, Cardiovascular Diseases, Pulmonary Hypertension
Abbott Medical Devices
Not applicable
850
Prague
2024-12-13
Recruiting
Biogen
Observational
300
Motol
2024-12-12
Recruiting
CardioFocus
Not applicable
100
Prague
2024-12-12
Recruiting
Boehringer Ingelheim
Phase 2
80
Hradec Králové, Prague
2024-12-11
Active, closed
Hoffmann-La Roche
Phase 3
350
Hradec Králové, Prague
2024-12-11
Recruiting
Novartis Pharmaceuticals
Phase 3
60
Prague
2024-12-09
By invitation
Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)
NCT06723106Antiphospholipid Syndrome (APS), Bullous Pemphigoid (BP), Behçet's Syndrome (BS), Dermatomyositis (DM)
DrugRAY121
Chugai Pharmaceutical
Phase 1
144
Prague
2024-12-09
Recruiting
Pfizer
Phase 3
2,330
Brno, Prague, České Budějovice, Protivín, Olomouc
2024-12-08
Recruiting
Closed-loop in Adults With Type 2 Diabetes
NCT06579404Type 2 Diabetes Treated With Insulin
University of Cambridge
Not applicable
224
Prague
2024-12-06
Recruiting
Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i.
NCT06382948Advanced Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer, ESR1 Gene Mutation
DrugsElacestrant·Everolimus
MedSIR
Phase 3
300
Brno, Hořovice, Olomouc, Prague, Zlín
2024-12-05
Active, closed
Janssen Research & Development, LLC
Phase 3
655
Brno, Karvina Frystat, Ostrava, Prague, Uherské Hradiště
2024-12-04
By invitation
A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
NCT06679946Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
DrugVutrisiran
Alnylam Pharmaceuticals
Phase 3
700
Prague
2024-12-03
Active, closed
Biogen
Phase 3
132
Czechia
2024-12-03
Recruiting
Cannabis Abstinence and Neurocognitive Assessment in Adolescence
NCT07160153Cannabis Dependence, Harmful Use, Cognitive Assessment
University Hospital Pilsen
Observational
29
Pilsen
2024-12-03
Recruiting
Novo Nordisk A/S
Phase 2
465
Český Krumlov, Frýdek-Místek, Hodonín, Prague, Smiřice
2024-12-02
Not yet open
High Flow Nasal Cannula for Stabilization of Extremely Premature Infants
NCT06683677Premature Infant, Ventilation Therapy, High Flow Nasal Canula
Charles University, Czech Republic
Not applicable
60
Prague
2024-12-01
Recruiting
Cardiopulmonary Exercise Testing in Cardiosurgery Patients
NCT06702059Postoperative Complications
St. Anne's University Hospital Brno, Czech Republic
Observational
130
Brno
2024-12-01
Active, closed
MEBSTER
Observational
6
Janske Lazne
2024-11-28
Active, closed
EyePoint Pharmaceuticals, Inc.
Phase 3
400
Náchod, Prague
2024-11-27
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,380
Brno, Hradec Králové
2024-11-25
Recruiting
Study SOLACE SEPSIS
NCT06634069Septic Shock, Intracranial Hypertension
DrugsSodium Lactate·NaCl
University Hospital Pilsen
Phase 2
40
Pilsen
2024-11-24
By invitation
Charles University, Czech Republic
Not applicable
15
Prague
2024-11-20
Recruiting
Takeda
Phase 3
30
Prague
2024-11-19
Active, closed
Daiichi Sankyo
Phase 3
700
Brno, Hradec Králové, Pilsen, Poruba, Prague
2024-11-19
Recruiting
Institute of Health Information and Statistics of the Czech Republic
Not applicable
1,000
Prague
2024-11-19
Active, closed
Pfizer
Phase 3
636
Brno, Hradec Králové, Ostrava, Prague
2024-11-15
Recruiting
Boehringer Ingelheim
Phase 3
1,590
Liberec, Pilsen, Prague
2024-11-12
Active, closed
argenx
Phase 2
87
Prague
2024-11-11
Active, closed
Santhera Pharmaceuticals
Phase 4
80
Brno, Prague
2024-11-10
Active, closed
Sanofi Pasteur, a Sanofi Company
Phase 1/2
750
Jindřichův Hradec, Ostrava, Pilsen, Prague
2024-11-05
Active, closed
Takeda
Phase 3
53
Brno, Prague
2024-11-04
Recruiting
Lifestyle for the BRAin Health - Time Restricted Eating and Mindfulness
NCT07042087Alzheimer Disease, Aging, Lifestyle Factors, Cognitive Impairment
St. Anne's University Hospital Brno, Czech Republic
Not applicable
48
Brno
2024-11-01
Recruiting
University Hospital Ostrava
Not applicable
100
Ostrava
2024-11-01
Recruiting
Epidemiological Factors and Optimization of Conservative Approaches to Precancerous Lesions of Female Reproductive Organs
NCT06967740Cervical Cancer, Cervical Intraepithelial Neoplasia (CIN), Risk Factors, Conservative Management
Nikola Janovska
Observational
200
Prague
2024-11-01
Recruiting
Palacky University
Not applicable
50
Olomouc
2024-11-01
Recruiting
Biodegradable Stents in Liver Transplant RecipIents for Treatment of Biliary Anastomotic Strictures
NCT06716541Liver Transplant, Complications, Biliary Anastomotic Stenosis, Endoscopic Retrograde Cholangiopancreatography
Institute for Clinical and Experimental Medicine
Not applicable
70
Prague
2024-11-01
Recruiting
Abivax S.A.
Phase 2
212
Brno, Hradec Králové, Olomouc, Prague, Slaný
2024-10-30
Active, closed
Novartis Pharmaceuticals
Phase 2
96
Olomouc, Prague
2024-10-29
Active, closed
A Study of Mosliciguat in PH-ILD
NCT06635850Pulmonary Hypertension, Interstitial Lung Disease, Lung Diseases, Vascular Diseases
DrugMosliciguat
Pulmovant, Inc.
Phase 2
135
Prague
2024-10-29
Recruiting
Novartis Pharmaceuticals
Phase 1/2
232
Prague
2024-10-24
Active, closed
CART123 T Cells in Relapsed or Refractory CD123+ Hematologic Malignancies: A Dose Escalation Phase I Trial
NCT06765876Leukemia, Myeloid, Acute(AML), Precursor Cell Lymphoblastic Leukemia-Lymphoma, Myelodysplastic Syndromes (MDS), Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Institute of Hematology and Blood Transfusion, Czech Republic
Early Phase 1
18
Prague
2024-10-23
Recruiting
Intra-Cellular Therapies, Inc.
Phase 2
320
Brno, Choceň, Kutná Hora, Pilsen, Prague
2024-10-22
Active, closed
Amgen
Phase 3
19
Prague
2024-10-22
Active, closed
Universitaire Ziekenhuizen KU Leuven
Not applicable
75
Olomouc
2024-10-22
Recruiting
Pfizer
Phase 3
900
Ostrava - Poruba, Olomouc, Pardubice, Prague, Liberec
2024-10-22
Active, closed
Pfizer
Phase 3
609
Olomouc, Pardubice, Prague
2024-10-21
Recruiting
argenx
Phase 3
69
Ostrava, Prague
2024-10-18
Active, closed
MoonLake Immunotherapeutics AG
Phase 3
960
Brno, Břeclav, Ostrava, Prague, Studénka, Zlín
2024-10-15
Active, closed
MoonLake Immunotherapeutics AG
Phase 3
600
Brno, Ostrava, Studénka, Zlín
2024-10-15
Recruiting
Boehringer Ingelheim
Phase 3
1,800
Liberec, Pilsen, Prague
2024-10-14
Recruiting
North Eastern German Society of Gynaecological Oncology
Phase 2
640
Ostrava, Prague
2024-10-11
Active, closed
Tomas Bata Hospital, Czech Republic
Observational
100
Zlín
2024-10-11
Active, closed
Ipsen
Phase 2
670
Brno, Choceň, Hradec Králové, Ostrava, Pardubice, Prague
2024-10-10
Active, closed
Incyte Corporation
Phase 3
346
Prague
2024-10-10
Recruiting
Enhancing Palliative Care in ICU
NCT06605079Palliative Care
Charite University, Berlin, Germany
Not applicable
2,040
Prague
2024-10-10
Active, closed
Eli Lilly and Company
Phase 2
143
Brno, Slaný, Zlín
2024-10-10
Active, closed
AbbVie
Phase 2
309
Kladno, Prague, Rychnov nad Kněžnou
2024-10-07
Recruiting
Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS)
NCT05947955Acute Respiratory Distress Syndrome, Infections
BioAegis Therapeutics Inc.
Phase 2
600
Brno, Prague
2024-10-03
Recruiting
Ferring Pharmaceuticals
Phase 3
454
Prague, Kroměříž, Liberec
2024-10-01
Recruiting
University Hospital, Geneva
Not applicable
220
Prague
2024-10-01
Not yet open
Charles University, Czech Republic
Not applicable
10
Prague
2024-10-01
Recruiting
Brno University Hospital
Not applicable
250
Brno
2024-10-01
Recruiting
Ferring Pharmaceuticals
Phase 3
250
Liberec, Prague, Kroměříž
2024-10-01
Not yet open
Charles University, Czech Republic
Observational
250
Prague
2024-10
By invitation
Open-Label Extension Study to Assess GLM101 in PMM2-CDG Patients
NCT06657859Pmm2-CDG, Phosphomannomutase 2 Deficiency
Glycomine, Inc.
Phase 2
90
Prague
2024-09-30
Active, closed
Stemline Therapeutics, Inc.
Phase 3
4,556
Brno, Hořovice, Prague
2024-09-27
By invitation
European Society of Cardiology
Observational
4,000
Brno, Broumov, České Budějovice, Havířov, Hradec Králové, Jaroměř, Motol, Náchod
2024-09-27
Active, closed
Boehringer Ingelheim
Phase 3
1,666
Prague
2024-09-26
Active, closed
Genmab
Phase 3
699
Olomouc, Prague
2024-09-25
Active, closed
A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hypertrophic Cardiomyopathy
NCT06481891Obstructive Cardiomyopathy, Hypertrophic, Non-obstructive Hypertrophic Cardiomyopathy
DrugSotagliflozin
Lexicon Pharmaceuticals
Phase 3
500
Brno, Prague, Ústí nad Labem
2024-09-24
Active, closed
Cerevance
Phase 3
330
Pardubičky, Prague, Brno, Hradec Králové
2024-09-20
Recruiting
Janssen Research & Development, LLC
Phase 2/3
274
Prague
2024-09-19
Active, closed
argenx
Phase 3
141
Brno, Pardubice
2024-09-18
Active, closed
Hoffmann-La Roche
Phase 3
400
Brno, České Budějovice, Hradec Králové
2024-09-17
Active, closed
A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis
NCT06431373Uveitis, Posterior, Uveitis, Intermediate, Uveitis
Priovant Therapeutics, Inc.
Phase 3
371
Prague
2024-09-11
Recruiting
Clinical Performance of Medical Device Software "Lipidica 1.0" for Processing Data Generated by Lipidomic Analysis in Pancreatic Cancer Screening
NCT06549725Pancreas Cancer, Pancreatic Ductal Adenocarcinoma, Hereditary Diseases, Pancreatitis, Chronic
Lipidica, a.s.
Not applicable
419
Prague, Brno, České Budějovice, Hradec Králové, Jablonec nad Nisou, Olomouc, Pardubice, Pilsen
2024-09-10
Recruiting
AbbVie
Phase 2
590
Hradec Králové, Prague, Brno
2024-09-04
Active, closed
Takeda
Phase 3
2,099
Náchod, Nový Jičín, Ostrava, Olomouc, Pardubice, Brno, Prague
2024-09-04
Active, closed
Novartis Pharmaceuticals
Phase 2
179
Olomouc, Prague
2024-09-04
Recruiting
Gossamer Bio USA, Inc.
Phase 3
330
Prague
2024-09-03
Not yet open
University Hospital Ostrava
Observational
100
Ostrava
2024-09-01
Active, closed
Masaryk University
Observational
6,276
Beroun, Blansko, Borovany, Brněnec, Brno, Bystřice pod Hostýnem, Čelákovice, Česká Kamenice
2024-09-01
Not yet open
Institute for Clinical and Experimental Medicine
Observational
200
Prague
2024-09-01
Recruiting
Marie Lulková
Not applicable
450
Ústí nad Labem
2024-09-01
Active, closed
argenx
Phase 2
33
Prague
2024-08-30
Active, closed
Alpine Immune Sciences Inc, A Subsidiary of Vertex
Phase 3
605
Brno, New Town, Nový Jičín
2024-08-30
Active, closed
Sanofi
Phase 2
229
Brno, Havířov, Klatovy, Prague
2024-08-29
Recruiting
Bayer
Phase 3
444
Nový Jičín, Ostrava - Vítkovice, Olomouc, Brno, Zlín
2024-08-28
Active, closed
Gilead Sciences
Phase 3
640
Nový Jičín, Ostrava-Poruba, Prague
2024-08-28
Active, closed
Zenas BioPharma (USA), LLC
Phase 2
93
Brno, Jihlava, Prague
2024-08-26
Recruiting
Mechanisms of Pulmonary Vascular Dysfunction in Heart Failure
NCT06331208Heart Failure, Pulmonary Hypertension, Pulmonary Vascular Resistance Abnormality
Institute for Clinical and Experimental Medicine
Observational
230
Prague
2024-08-23
Active, closed
Kite, A Gilead Company
Phase 3
452
Severomoravsky KRAJ
2024-08-23
Recruiting
Vojtech Melenovsky, MD, PhD
Observational
120
Prague
2024-08-23
Recruiting
Sanofi
Phase 3
160
Brno, Hradec Králové, Ostrava, Pardubice, Prague
2024-08-21
Recruiting
Octapharma
Phase 3
120
Brno, Prague
2024-08-21
Recruiting
Colorado Prevention Center
Phase 3
2,600
Brno
2024-08-20
Recruiting
Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
NCT06371417Antiphospholipid Syndrome (APS), Bullous Pemphigoid (BP), Behçet's Syndrome (BS), Dermatomyositis (DM)
DrugRAY121
Chugai Pharmaceutical
Phase 1
144
Prague
2024-08-19
Recruiting
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
NCT06395103B-cell Acute Lymphoblastic Leukemia, Diffuse Large B-cell Lymphoma, Burkitt Lymphoma, Neuroblastoma
DrugZilovertamab vedotin
Merck Sharp & Dohme LLC
Phase 1/2
90
Brno, Prague
2024-08-16
Recruiting
Intra-Cellular Therapies, Inc.
Phase 2
370
Brno, Hradec Králové, Prague
2024-08-15
Active, closed
Genmab
Phase 3
379
Hradec Králové, Prague, Olomouc
2024-08-13
Recruiting
AstraZeneca
Phase 3
620
Brno, Hradec Králové, Olomouc, Prague
2024-08-12
Recruiting
AstraZeneca
Phase 3
1,018
Brno, Hradec Králové, Prague
2024-08-07
Recruiting
VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease
NCT06257706Moderately to Severely Active Crohn's Disease, Crohn Disease, Disease Crohn
DrugVedolizumab
Alimentiv Inc.
Phase 4
304
Brno
2024-08-07
Active, closed
EyeBiotech Ltd.
Phase 2/3
984
Mladá Boleslav, Náchod, Prague
2024-08-07
Recruiting
Intra-Cellular Therapies, Inc.
Phase 2
705
Brno, Pilsen, Prague
2024-08-05
Active, closed
Merck Sharp & Dohme LLC
Phase 3
3,000
Brno, Prague
2024-08-05
Active, closed
Iptacopan in Patients With ANCA Associated Vasculitis
NCT06388941Anti-Neutrophil Cytoplasm Antibodies (ANCA) Associated Vasculitis
DrugsIptacopan·Rituximab
Novartis Pharmaceuticals
Phase 2
84
Prague
2024-08-05
Recruiting
AstraZeneca
Phase 3
788
Brno, Hořovice, Hradec Králové, Olomouc, Prague
2024-08-01
By invitation
AOP Orphan Pharmaceuticals AG
Observational
110
Olomouc, Prague
2024-07-31
Recruiting
NovoCure GmbH
Phase 3
734
Olomouc, Ostrava, Prague
2024-07-31
Active, closed
Astellas Pharma Global Development, Inc.
Phase 3
982
České Budějovice, Hořovice, Hradec Králové, Nový Jičín, Olomouc, Prague, Tábor, Vodňany
2024-07-31
Active, closed
Annexon, Inc.
Phase 3
659
Prague
2024-07-30
By invitation
Viatris Innovation GmbH
Phase 3
680
Brno, Prague
2024-07-30
By invitation
Biohaven Therapeutics Ltd.
Phase 2
660
Prague, Brno
2024-07-30
Recruiting
CellFX® Nanosecond Pulsed Field Ablation (PFA) 360 Catheter Ablation System for Treatment of Atrial Fibrillation
NCT06696170Atrial Fibrillation Paroxysmal, Cardiac Ablation, Cardiac Arrhythmia
Pulse Biosciences, Inc.
Not applicable
60
Prague
2024-07-25
Recruiting
Endocardial Mapping With the CoreMap EP Mapping System
NCT06529978Persistent Atrial Fibrillation
CoreMap Inc.
Not applicable
245
Praha Klanovice
2024-07-25
Active, closed
The Field PULSE Study
NCT06452589Atrial Arrhythmias
Field Medical
Not applicable
35
Prague
2024-07-25
Recruiting
Janssen Research & Development, LLC
Phase 3
752
Brno, Pilsen, Prague
2024-07-25
Recruiting
Stimvia s.r.o.
Not applicable
20
Ostrava
2024-07-19
Recruiting
Jazz Pharmaceuticals
Phase 3
286
Brno, Hradec Králové, Prague
2024-07-19
Active, closed
Scanning the Meiotic Spindle in Assisted Reproductive Techniques to Assess Oocyte Quality
NCT06539585Infertility, Infertility, Male, Infertility, Female
Charles University, Czech Republic
Not applicable
164
Prague
2024-07-18
Recruiting
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
Phase 2
385
Brno, Prague
2024-07-18
Active, closed
Vor Biopharma
Phase 3
191
Ostrava-Poruba, Brno
2024-07-17
Recruiting
Amgen
Phase 3
450
Brno, Hradec Králové, Olomouc, Prague
2024-07-17
Recruiting
Heidelberg University
Observational
4,000
Prague
2024-07-16
Recruiting
Molecular Classification in Relation to Prevention of Endometrial Cancer Recurrence and Lifestyle Factors
NCT06680791Endometrial Cancer, Genetic Predisposition, Risk Behavior
Lukas Vanek
Observational
280
Prague
2024-07-15
Active, closed
A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work
NCT06290128Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Polyneuropathy, Inflammatory Demyelinating, Chronic
DrugRiliprubart
Sanofi
Phase 3
109
Brno, Hradec Králové, Pardubice
2024-07-12
Active, closed
Celldex Therapeutics
Phase 3
963
Prague
2024-07-11
Active, closed
Novartis Pharmaceuticals
Phase 2
155
Brno, Prague, Uherské Hradiště
2024-07-02
Recruiting
AI-POD Clinical Validation Study for Obese Patients
NCT06595134Acute Cardiovascular Disease
University Hospital, Bonn
Observational
1,200
Pilsen
2024-07-01
Active, closed
Novartis Pharmaceuticals
Phase 3
162
Prague, Brno, Hlučín, Uherské Hradiště
2024-06-28
Recruiting
argenx
Phase 2/3
12
Brno, Ostrava
2024-06-28
Active, closed
AbbVie
Phase 3
1,400
Ostrava, Karlovy Vary, Prague
2024-06-27
Active, closed
Genmab
Phase 3
621
Olomouc
2024-06-25
Active, closed
Novo Nordisk A/S
Phase 3
10,000
Liberec, Ústní Nad Labem, Brno, České Budějovice, Olomouc, Pardubice, Plzen - Lochotín, Prague
2024-06-25
Active, closed
UCB Biopharma SRL
Phase 3
176
Plzen-bory
2024-06-25
Recruiting
SpliSense Ltd.
Phase 2
64
Prague
2024-06-24
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,530
Brno, Olomouc, Prague, České Budějovice
2024-06-24
Recruiting
Institute for Clinical and Experimental Medicine
Not applicable
40
Prague
2024-06-20
Recruiting
AstraZeneca
Phase 3
240
Prague
2024-06-20
Active, closed
Celgene
Phase 3
850
Brno, Hradec Králové, Olomouc, Pilsen, Prague
2024-06-19
Recruiting
Boehringer Ingelheim
Phase 3
6,712
Bílovec, Brandýs nad Labem, Brno, Chrudim, Havlíčkův Brod, Jablonec nad Nisou, Jihlava, Litovel
2024-06-17
Recruiting
Merck Sharp & Dohme LLC
Phase 3
851
Brno, Ostrava-Vitkovice, Pardubice, Olomouc
2024-06-10
Active, closed
Exelixis
Phase 2/3
600
Nový Jičín, Olomouc, Prague
2024-06-07
Recruiting
X4 Pharmaceuticals
Phase 3
176
Brno, Prague
2024-06-06
Recruiting
Immunocore Ltd
Phase 3
680
Hradec Králové, Olomouc, Prague
2024-06-05
Active, closed
Amgen
Phase 3
563
Brno, Olomouc, Ostrava-Vitkovice, Prague
2024-06-05
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,200
Brno, Slaný, Prague, Hradec Králové
2024-06-05
Recruiting
Spinocerebellar Ataxia Type 27B Natural History Study (SCA27B-NHS)
NCT06472557Spinocerebellar Ataxia Type 27B
University Hospital Tuebingen
Observational
300
Prague
2024-06-04
Recruiting
Kartos Therapeutics, Inc.
Phase 3
600
Brno, Hradec Králové, Ostrava, Prague
2024-06-03
Active, closed
Janssen Research & Development, LLC
Phase 2
333
Brno-Bohunice, Hradec Králové, Olomouc, Ostrava - Poruba, Prague
2024-05-30
Active, closed
Stealth BioTherapeutics Inc.
Phase 3
313
Prague
2024-05-30
Recruiting
Novartis Pharmaceuticals
Phase 3
550
Brno, Prague, Uherské Hradiště
2024-05-21
Recruiting
Daiichi Sankyo
Phase 3
540
Liberec, Olomouc, Prague
2024-05-21
Recruiting
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
NCT06237452Clostridium Difficile, Clostridium Difficile Infections, Clostridium Difficile Infection Recurrence, Clostridioides Difficile Infection
Vedanta Biosciences, Inc.
Phase 3
852
Brno, Kyjov, Ostrava-Poruba
2024-05-20
Active, closed
AbbVie
Phase 3
421
Brno, Ostrava, Prague, Hradec Králové
2024-05-19
Recruiting
Novartis Pharmaceuticals
Phase 3
65
Ostrava
2024-05-08
Active, closed
Sanofi
Phase 3
1,541
Kutná Hora, Nový Jičín, Olomouc, Ostrava, Pilsen, Prague
2024-05-08
Recruiting
UHF ECG in LBBB and Response to CRT Prediction
NCT07057544Left Bundle Branch Block, Left Bundle Branch Area Pacing, Biventricular Pacing, Intraventricular Conduction Delay
Faculty Hospital Kralovske Vinohrady
Not applicable
200
Prague
2024-05-01
Active, closed
SOTIO Biotech AG
Phase 1
40
Brno
2024-05-01
Recruiting
Charles University, Czech Republic
Not applicable
60
Prague
2024-05-01
Recruiting
Masaryk University
Not applicable
65
Brno
2024-05-01
Active, closed
Eli Lilly and Company
Phase 3
10,000
Brandýs nad Labem, Brno, Chlumec nad Cidlinou, Český Krumlov, Holešov, Kolín, Litovel, Náchod
2024-04-30
Active, closed
A Study Evaluating APG777 in Atopic Dermatitis
NCT06395948Atopic Dermatitis
DrugAPG777
Apogee Therapeutics, Inc.
Phase 2
470
Prague
2024-04-29
Active, closed
Erasca, Inc.
Phase 3
78
Brno, Nový Hradec Králové, Prague
2024-04-29
Recruiting
CSL Behring
Phase 2/3
3,110
Český Krumlov, Hradec Králové, Nový Jičín, Ostrava, Prague
2024-04-27
By invitation
ACADIA Pharmaceuticals Inc.
Phase 3
752
Brno, Kladno, Prague, Rychnov nad Kněžnou
2024-04-23
By invitation
Optimizing the Assessment of Mechanical Ventilation by Integrating Advanced Monitoring Techniques [AVIM]
NCT06236685Mechanical Ventilation Complication, Ventilator-Induced Lung Injury
Czech Technical University in Prague
Not applicable
100
Prague
2024-04-22
Recruiting
Karyopharm Therapeutics Inc
Phase 2
58
Olomouc
2024-04-22
Recruiting
Motor Development and Early Predictors of Psychomotor Outcomes in Preterm and Term Infants Assessed by MOS-R and Caregiver Questionnaire at 18 and 36 Months
NCT07296003Neurodevelopmental Disorders, Motor Skills Disorders, Infant, Premature Development, Infant, Term Development
Masaryk University
Observational
60
Pardubice
2024-04-19
Active, closed
Biomarkers of Steatohepatitis in Type 2 Diabetes Patients
NCT07098520Diabetes, Steatosis of Liver
Faculty Hospital Kralovske Vinohrady
Observational
100
Prague
2024-04-18
Recruiting
Janssen Research & Development, LLC
Phase 3
641
Hradec Králové, Olomouc, Prague
2024-04-18
Active, closed
Janssen-Cilag Ltd.
Phase 3
120
České Budějovice, Hradec Králové, Prague
2024-04-17
Active, closed
A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.
NCT06372145Relapsing Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Progressive Relapsing Multiple Sclerosis
DrugTeriflunomide
Sanofi
Phase 3
2,500
Brno, Hradec Králové, Jihlava, Ostrava - Poruba, Pardubice, Prague, Praha 5 - Motol, Teplice
2024-04-16
Active, closed
argenx
Phase 3
119
Brno, Pardubice
2024-04-16
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,200
Ostrava-Poruba, Olomouc, České Budějovice, Prague
2024-04-14
Recruiting
AstraZeneca
Phase 3
3,850
Brno, Broumov, Česká Lípa, Jaroměř, Louny, Ostrava, Pilsen, Plzen - Bory
2024-04-12
Recruiting
CARE1 Pragmatic Clinical Trial
NCT06364631Metastatic Kidney Cancer, Metastatic Kidney Carcinoma
DrugsAxitinib·Cabozantinib·Yervoy·Ipilimumab
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3
1,250
Brno, Hradec Králové, Olomouc, Prague
2024-04-12
Recruiting
Invasive Candidiasis in Critical Care
NCT06456151Invasive Candidiasis
University Hospital Ostrava
Observational
100
Ostrava, Prague
2024-04-11
Active, closed
Almirall, S.A.
Observational
42
Ostrava, Pilsen, Prague, Ústí nad Labem
2024-04-04
Recruiting
Region Örebro County
Phase 3
800
Brno
2024-04-04
Recruiting
Merck Sharp & Dohme LLC
Phase 3
780
Brno, Ostrava
2024-04-03
Active, closed
Amgen
Phase 4
32
Prague
2024-04-02
Recruiting
Jan Žatecký
Observational
40
Opava
2024-04-01
By invitation
Reducing Non-Alcoholic Steatohepatitis
NCT06519448Non-alcoholic Steatohepatitis, Liver Diseases, Diabetes Mellitus, Type 2, Fibrosis, Liver
Military University Hospital, Prague
Not applicable
30
Prague
2024-04-01
Active, closed
Novo Nordisk A/S
Phase 3
673
Benešov, Brno, Chomutov, Prague, Svitavy, Trutnov, Třinec
2024-04-01
Recruiting
Institute for Clinical and Experimental Medicine
Not applicable
25
Prague
2024-04-01
Active, closed
Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)
NCT06291376Immunoglobulin A Nephropathy, IgAN
DrugRavulizumab
Alexion Pharmaceuticals, Inc.
Phase 3
584
Nový Jičín, Prague
2024-03-29
Active, closed
Takeda
Phase 2
213
Hořovice, Brno, Hradec Králové, Ostrava, Ostrava-Poruba, Pardubice, Prague, Ústí nad Labem
2024-03-29
Active, closed
AstraZeneca
Phase 3
2,554
Frýdek-Místek, Jilemnice, Krnov, Náchod, Olomouc, Police nad Metují, Prague, Třebíč
2024-03-29
Active, closed
Gilead Sciences
Phase 2
228
Olomouc, Slaný
2024-03-27
Recruiting
GlaxoSmithKline
Phase 3
864
Olomouc, Prague, Zlín
2024-03-21
Recruiting
National Institute of Mental Health, Czech Republic
Not applicable
30
Klecany
2024-03-20
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
411
Brno
2024-03-15
Active, closed
Biohaven Therapeutics Ltd.
Phase 2/3
390
Brno
2024-03-14
Recruiting
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
NCT06318169Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
DrugPegozafermin
Hoffmann-La Roche
Phase 3
1,350
Brno, Ostrava, Pilsen
2024-03-13
Recruiting
Novartis Pharmaceuticals
Phase 3
450
Ostrava, Olomouc, Prague
2024-03-12
Recruiting
The NEU-STIM Trial
NCT05942924Infant, Premature, Diseases, Birth, Preterm
Leiden University Medical Center
Not applicable
3,280
Prague
2024-03-11
Recruiting
Novartis Pharmaceuticals
Phase 2
502
Hradec Králové, Jaroměř, Prague
2024-03-07
Active, closed
Eli Lilly and Company
Phase 3
17,300
Brandýs nad Labem, Brno, Litovel, Náchod, Olomouc, Ostrava, Prague, Říčany
2024-03-05
Recruiting
Takeda
Phase 2
268
Hořovice, Brno, České Budějovice, Hradec Králové, Ostrava, Ostrava-Poruba, Pardubice, Prague
2024-03-05
Recruiting
Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study.
NCT06280755Multiple Sclerosis, NMO Spectrum Disorder, Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease, Radiologically Isolated Syndrome
icometrix
Observational
7,000
Prague
2024-03-01
Recruiting
medac GmbH
Phase 3
277
Prague, Olomouc, Ostrava, Pardubice
2024-02-27
Recruiting
Daiichi Sankyo
Phase 2/3
860
Brno, Hradec Králové, Prague
2024-02-27
Active, closed
Dianthus Therapeutics
Phase 2
65
Ostrava
2024-02-23
Active, closed
AstraZeneca
Phase 2
142
Brno, Olomouc, Prague
2024-02-22
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
762
Ostrava, Prague
2024-02-21
Recruiting
AstraZeneca
Phase 3
5,250
Brandýs nad Labem, Jindřichův Hradec, Olomouc, Ostrava, Prague, Rokycany, Tábor
2024-02-21
Active, closed
Novo Nordisk A/S
Phase 2
88
Prague
2024-02-20
Recruiting
Italfarmaco
Phase 3
138
Prague
2024-02-19
Active, closed
AbbVie
Observational
1,200
Brno, České Budějovice
2024-02-19
Recruiting
Pfizer
Phase 3
492
Brno, Prague
2024-02-08
Recruiting
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
NCT06072482Antineutrophil Cytoplasmic Antibody-associated Vasculitis
DrugAvacopan
Amgen
Phase 4
300
Hradec Králové, Olomouc, Ostrava - Poruba, Pilsen, Prague
2024-02-07
Active, closed
Genmab
Phase 3
1,095
Brno, Hradec Králové, Prague
2024-02-05
Recruiting
General University Hospital, Prague
Observational
250
Prague
2024-02-01
Active, closed
Incyte Corporation
Phase 3
617
Ostrava - Poruba, Prague
2024-01-30
Recruiting
Genexine, Inc.
Phase 3
429
Český Krumlov, Havlíčkův Brod, Pilsen, Teplice
2024-01-25
Active, closed
Sanofi
Phase 3
260
Brno, Hradec Králové, Ostrava, Prague
2024-01-23
Active, closed
Janssen Research & Development, LLC
Phase 3
838
Brno-Bohunice, Hradec Králové, Olomouc, Ostrava
2024-01-22
Recruiting
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
NCT06162221Non-Small Cell Lung Cancer, NSCLC, KRAS, NRAS, HRAS-mutated NSCLC, KRAS G12C-mutated Solid Tumors, Lung Cancer, Lung Cancer Stage IV, Advanced Solid Tumor, Cancer
DrugsElironrasib·RMC-9805·Cetuximab·Pemetrexed
Revolution Medicines, Inc.
Phase 1/2
616
Nový Jičín
2024-01-18
Recruiting
Colorado Prevention Center
Phase 3
5,200
Chlumec nad Cidlinou, Pilsen, Brno, Prague, Roudnice nad Labem
2024-01-17
Active, closed
Pancreatic Antibiotic Concentration Evaluation Assessment
NCT07084428Acute Pancreatic Fluid Collection, Acute Pancreatitis
Brno University Hospital
Observational
40
Brno
2024-01-15
Recruiting
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
NCT06064877Metastatic Head-and-neck Squamous-cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma
DrugsErbitux·Cetuximab
AVEO Pharmaceuticals, Inc.
Phase 3
410
Brno, Olomouc, Prague
2024-01-11
Active, closed
Study of ALXN2220 Versus Placebo in Adults With ATTR-CM
NCT06183931Transthyretin Amyloid Cardiomyopathy
DrugCliramitug
Alexion Pharmaceuticals, Inc.
Phase 3
1,182
Prague
2024-01-11
By invitation
5-SENSE Score Validation Study
NCT06138808Epilepsy Intractable
Duke University
Observational
400
Brno
2024-01-09
Recruiting
Aftificial Inteligence in Assisted Reproductive Techniques to Assess Oocyte Quality and Embryo Ploidy
NCT06539104Infertility, Infertility, Female, Infertility, Male, Infertility Unexplained
Charles University, Czech Republic
Observational
1,000
Prague, Vestec
2024-01-05
Active, closed
Novartis Pharmaceuticals
Phase 2
49
Olomouc
2024-01-03
By invitation
Sanofi
Phase 3
90
Prague
2024-01-03
Recruiting
Multimodal Cardiac Imaging Registry in Patients with Atrial Fibrillation
NCT06584266Atrial Fibrillation and Flutter, Heart Failure, Artificial Intelligence (AI), Echocardiography
University in Zielona Góra
Observational
3,000
Brno
2024-01-01
By invitation
University Hospital Pilsen
Not applicable
150
Pilsen
2024-01-01
Recruiting
SpiroGym App-Aided Cough Rehabilitation
NCT06481540Parkinson Disease, Voluntary Peak Cough Strength, mHealth
General University Hospital, Prague
Not applicable
60
Prague
2024-01-01
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,310
Brno, Ostrava, Olomouc, Prague
2023-12-31
Recruiting
Regeneron Pharmaceuticals
Phase 3
580
Hradec Králové, Brno, Prague
2023-12-28
Active, closed
Sanofi
Phase 3
943
Brno, Hradec Králové, Jihlava, Ostrava, Prague, Teplice, Zlín
2023-12-27
Recruiting
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
NCT06059638Hypertension, Hypertension, Systolic, Hypertension, Essential
Orchestra BioMed, Inc
Not applicable
316
Prague
2023-12-27
Active, closed
Affera Global Registry
NCT06026345Atrial Fibrillation
Medtronic Cardiac Ablation Solutions
Observational
540
Prague
2023-12-22
Recruiting
Eli Lilly and Company
Phase 3
1,264
Ostrava, Prague
2023-12-21
Recruiting
PARa-aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer
NCT05581121Cervical Carcinoma, Adenocarcinoma, Adenosquamous Carcinoma
Institut Claudius Regaud
Phase 3
510
Ostrava, Pilsen, Prague
2023-12-20
Recruiting
Ascentage Pharma Group Inc.
Phase 3
400
Hradec Králové
2023-12-20
Recruiting
First in Human Study of the Icoms Flowmaker
NCT07632586Advanced Heart Failure
FineHeart
Not applicable
10
Prague
2023-12-19
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,314
Brno, Liberec, Prague, Olomouc
2023-12-18
Recruiting
Merck Sharp & Dohme LLC
Phase 3
614
Ostrava, Pardubice, Prague, Olomouc
2023-12-15
Recruiting
Intellia Therapeutics
Phase 3
1,200
Brno
2023-12-13
Recruiting
Regeneron Pharmaceuticals
Phase 3
904
Hradec Králové, Brno, Prague
2023-12-13
Active, closed
Sanofi
Phase 3
1,655
Brno, Hradec Králové, Jihlava, Ostrava, Pardubice, Prague, Teplice, Zlín
2023-12-13
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,200
Hradec Králové, Olomouc, Prague
2023-12-13
Recruiting
Regeneron Pharmaceuticals
Phase 3
822
Hradec Králové, Prague
2023-12-12
Active, closed
Syndax Pharmaceuticals
Phase 2
145
Prague
2023-12-11
Active, closed
Sanofi
Phase 2
197
Ostrava, Prague
2023-12-11
Recruiting
AbbVie
Phase 3
110
Prague
2023-12-11
Active, closed
Merck Sharp & Dohme LLC
Phase 3
710
Brno, Ostrava, Nový Jiín, Olomouc, Prague
2023-12-06
Active, closed
Merck Sharp & Dohme LLC
Phase 3
868
Brno, Ostrava, Olomouc, Prague
2023-12-06
Recruiting
AOP Orphan Pharmaceuticals AG
Phase 4
110
Olomouc, Prague
2023-12-06
Active, closed
Aura Biosciences
Phase 3
108
Prague, Pilsen
2023-12-06
Active, closed
AOP Orphan Pharmaceuticals AG
Phase 3
117
Brno, Prague
2023-12-04
Active, closed
CERebrolysin In CADASIL
NCT05755997Cadasil
DrugsCerebrolysin·NaCl
Ever Neuro Pharma GmbH
Phase 2
30
Prague
2023-11-29
Active, closed
argenx
Observational
413
Brno, Hradec Králové
2023-11-29
Recruiting
Novartis Pharmaceuticals
Phase 2/3
232
Brno
2023-11-24
Active, closed
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
NCT06016738Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer
DrugsPalazestrant·Exemestane·Anastrozole·Letrozole
Olema Pharmaceuticals, Inc.
Phase 3
510
Hradec Králové, Nový Jičín, Olomouc, Brno, Prague
2023-11-16
Recruiting
Charite University, Berlin, Germany
Not applicable
3,595
Olomouc, Prague, Ústí nad Labem
2023-11-16
Recruiting
Amgen
Phase 3
750
Brno, Hradec Králové, Olomouc, Pilsen
2023-11-16
Active, closed
Nektar Therapeutics
Phase 2
396
Brno, Pardubice, Prague
2023-11-15
Active, closed
Novartis Pharmaceuticals
Phase 3
470
Brno, Plzen Bolevec, Prague
2023-11-15
Active, closed
AbbVie
Phase 3
289
Prague, České Budějovice
2023-11-15
Active, closed
Regeneron Pharmaceuticals
Phase 3
733
Hradec Králové, Brno
2023-11-14
Recruiting
ACP-204 in Adults With Alzheimer's Disease Psychosis
NCT06159673Alzheimer's Disease Psychosis
DrugACP-204
ACADIA Pharmaceuticals Inc.
Phase 2/3
1,074
Kladno, Prague, Brno, Choceň, Rychnov nad Kněžnou
2023-11-14
Active, closed
Merck Sharp & Dohme LLC
Phase 3
556
Brno, Ostrava, Pilsen, Olomouc, Prague
2023-11-12
Active, closed
BeOne Medicines
Phase 3
652
Brno, Hradec Králové, Olomouc, Ostrava, PLZE, Prague
2023-11-11
Active, closed
Xentria, Inc.
Phase 1/2
32
Prague
2023-11-10
Active, closed
AbbVie
Phase 3
122
Pilsen, Prague
2023-11-06
Active, closed
Amgen
Phase 3
633
Hradec Kralove, Prague
2023-11-02
Recruiting
Institut Curie
Not applicable
600
Prague
2023-11-02
Active, closed
PAMNEU - Memory in Neurology
NCT06154564Cognitive Impairment
Charles University, Czech Republic
Observational
600
Prague
2023-11-01
Recruiting
University Hospital Ostrava
Observational
40
Ostrava
2023-11-01
Recruiting
Trifecta-Lung cfDNA-MMDx Study
NCT05837663Lung Transplantation
University of Alberta
Observational
600
Prague
2023-11-01
Active, closed
Novartis Pharmaceuticals
Phase 3
612
Brno, Uherské Hradiště
2023-10-27
Active, closed
Bristol-Myers Squibb
Phase 3
1,057
Prague
2023-10-25
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,109
Brno, Slaný, Prague, Hradec Králové
2023-10-25
Active, closed
AstraZeneca
Phase 3
895
Olomouc, Ostrava - Vitkovice, Prague
2023-10-24
Active, closed
VOLT CE Mark Study
NCT06106594Atrial Arrhythmia, Atrial Fibrillation, Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation
Abbott Medical Devices
Not applicable
300
Prague
2023-10-24
Active, closed
Bristol-Myers Squibb
Phase 3
402
Brno, Ostrava, Prague
2023-10-24
Active, closed
Cortex
Not applicable
400
Brno, Prague
2023-10-23
Recruiting
Confocal Laser Endomicroscopy VERification
NCT06079970Lung Cancer, Lung Neoplasm Malignant, Carcinoma, Non-Small-Cell Lung, Neoplasm of Lung
Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)
Not applicable
208
Prague
2023-10-18
Recruiting
Real-world Usage of HyQvia in Multiple Myeloma Adults With Secondary Immunodeficiency
NCT05879757Multiple Myeloma, Secondary Immunodeficiency (SID)
Takeda
Observational
75
Pilsen, Prague
2023-10-17
Active, closed
Eli Lilly and Company
Phase 3
160
Olomouc, Ostrava, Prague, Jihlava
2023-10-16
Active, closed
Ipsen
Phase 3
759
Brno, Hradec Králové, Jihlava, Ostrava - Poruba, Prague
2023-10-12
Recruiting
Sanofi
Phase 3
180
Olomouc, Prague
2023-10-10
Active, closed
Stichting European Myeloma Network
Phase 3
759
Brno, Králová, Ostrava, Pilsen
2023-10-10
Active, closed
Bristol-Myers Squibb
Phase 3
106
Prague
2023-10-05
Active, closed
AstraZeneca
Phase 3
5,511
Brno, Liberec, Pardubice, Prague
2023-10-05
Recruiting
Novartis Pharmaceuticals
Phase 3
106
Prague
2023-10-02
Active, closed
Novartis Pharmaceuticals
Phase 3
109
Ostrava
2023-10-02
Recruiting
University Hospital Pilsen
Observational
100
Pilsen
2023-10-01
Recruiting
University Hospital Ostrava
Observational
3,000
Ostrava, České Budějovice
2023-10-01
Active, closed
Ipsen
Phase 3
751
Brno, Choceň, Jihlava, Ostrava, Prague
2023-09-29
Recruiting
Charles University, Czech Republic
Phase 3
60
Prague
2023-09-27
Active, closed
Astria Therapeutics, Inc.
Phase 2
56
Hradec Králové
2023-09-26
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
412
Hradec Králové, Olomouc
2023-09-22
By invitation
Denali Therapeutics Inc.
Phase 2/3
99
Prague
2023-09-20
By invitation
argenx
Phase 3
240
Prague
2023-09-12
Recruiting
Orchid Pharma Europe GmbH
Phase 2
40
Hradec Králové, Kolín
2023-09-11
Recruiting
Biotest
Phase 3
590
Brno, Kolín, Kyjov, Prague
2023-09-09
Active, closed
Boehringer Ingelheim
Phase 2
268
Kralupy nad Vltavou, Prague
2023-09-08
Recruiting
Rescue of Nephrons With ALE.F02 (RENAL-F02)
NCT06047171Glomerulonephritis Rapidly Progressive
DrugsCyclophosphamid·Rituximab
Alentis Therapeutics AG
Phase 2
80
Prague
2023-09-07
Recruiting
Gilead Sciences
Phase 3
402
Ostrava, Pilsen, Prague
2023-09-07
Recruiting
Masaryk University
Observational
700
Brno
2023-09-07
By invitation
Telemedicine Self-examination of Speech and Memory for Rapid Detection of Cognitive Impairments Using Machine Learning Methods
NCT07558785Mild Cognitive Impairment (MCI), Dementia, Mild Cognitive Impairment (MCI) Amnestic, Frontotemporal Degeneration (FTD)
Faculty Hospital Kralovske Vinohrady
Not applicable
500
Pilsen, Prague
2023-09-01
Active, closed
Enlighten Study: The EV-ICD Post Approval Registry
NCT06048731Ventricular Arrhythmia, Tachycardia
Medtronic
Observational
1,000
Prague
2023-09-01
Recruiting
Ipsen
Phase 3
276
Hradec Králové, Liberec, Ostrava, Pilsen, Prague
2023-08-31
Recruiting
A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)
NCT06051409Ph+ ALL, Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
DrugOlverembatinib
Ascentage Pharma Group Inc.
Phase 3
350
Brno, Hradec Králové, Ostrava, Prague
2023-08-31
Active, closed
Teva Branded Pharmaceutical Products R&D LLC
Phase 3
2,769
Brandýs nad Labem-Stará Boleslav, Brno, Jihlava, Jindřichův Hradec, Lovosice, Ostrava, Prague, Varnsdorf
2023-08-30
Recruiting
General University Hospital, Prague
Not applicable
100
Prague
2023-08-30
Active, closed
rTMS-enhanced Psychotherapy for Borderline Personality Disorder
NCT06259851Borderline Personality Disorder
Masarykova Univerzita
Not applicable
60
Brno
2023-08-20
Recruiting
Novartis Pharmaceuticals
Phase 4
700
Olomouc, Prague
2023-08-14
Recruiting
Faculty Hospital Kralovske Vinohrady
Not applicable
9
Prague
2023-08-08
Active, closed
Hoffmann-La Roche
Phase 3
459
Hradec Králové, Prague
2023-08-08
Active, closed
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Observational
366
Brno, Hradec Králové, Ostrava, Teplice
2023-08-03
Recruiting
Ischemic And Bleeding Risk Assessment After TAVR
NCT06000943Aortic Valve Stenosis, Transcatheter Aortic Valve Replacement
Niguarda Hospital
Observational
2,500
Prague
2023-08-01
Recruiting
GlaxoSmithKline
Phase 3
892
Hradec Králové, Nový Jičín, Prague
2023-08-01
Active, closed
Belite Bio, Inc
Phase 3
429
Ostrava, Prague
2023-07-27
Active, closed
Eagle Pharmaceuticals, Inc.
Phase 2
276
Teplice, Ústí nad Labem, Zizkova
2023-07-22
Recruiting
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
1,000
Prague, Kutná Hora, Pilsen, Rychnov nad Kněžnou
2023-07-11
Active, closed
A Study of Zigakibart in Adults With IgA Nephropathy
NCT05852938IgA Nephropathy, Immunoglobulin A Nephropathy
DrugZigakibart
Novartis Pharmaceuticals
Phase 3
383
Prague
2023-07-06
Active, closed
Hansa Biopharma AB
Phase 3
150
Prague
2023-07-03
Recruiting
University Hospital Ostrava
Observational
150
Ostrava
2023-07-01
Recruiting
University Hospital Ostrava
Observational
200
Ostrava
2023-07-01
Recruiting
Global Research Initiative for Patients Screening on MASH
NCT05651724MASH, MASLD, MASH With Fibrosis, Fibrosis, Liver
Julius Clinical
Observational
10,000
Prague
2023-06-30
Active, closed
Hoffmann-La Roche
Phase 3
2,000
Brandýs nad Labem-Stará Boleslav, Hradec Králové, Jind?ich?v Hradec, Kralupy nad Vltavou, Opava, Prague, Tábor, Teplice
2023-06-28
Recruiting
Friedreich's Ataxia Research Alliance
Observational
3,000
Prague
2023-06-28
Active, closed
Viatris Innovation GmbH
Phase 3
451
Brno, Prague
2023-06-26
Active, closed
Swedish Orphan Biovitrum
Observational
165
Brno, Prague
2023-06-26
Active, closed
Bristol-Myers Squibb
Phase 3
1,230
Brno, Olomouc, Prague
2023-06-22
Active, closed
Cutting Edge SAS
Not applicable
251
Vyškov, Zlín
2023-06-21
Recruiting
Novel Setup Algorithm for Cardiac Neuromodulation Therapy
NCT05719454Hypertension, Bradycardia
BackBeat Medical Inc
Not applicable
30
Prague
2023-06-21
Active, closed
AbbVie
Phase 3
1,328
Prague, Karlovy Vary
2023-06-21
Recruiting
The Institute of Molecular and Translational Medicine, Czech Republic
Not applicable
3,200
Brno, Olomouc, Prague
2023-06-01
Recruiting
Pericoronary Adipocyte Size Gradient
NCT07360925Heart Failure, Heart Transplantation
Institute for Clinical and Experimental Medicine
Observational
60
Prague
2023-06-01
Active, closed
Amgen
Phase 3
509
Brno, Olomouc, Ostrava-Vitkovice, Prague
2023-05-31
Recruiting
Early Diagnosis of Invasive Lung Aspergillosis
NCT05860387Respiratory Infection, Invasive Pulmonary Aspergillosis
University Hospital Ostrava
Observational
150
Havířov, Krnov, Ostrava, Olomouc
2023-05-31
Active, closed
Apellis Pharmaceuticals, Inc.
Phase 3
100
Prague
2023-05-29
Recruiting
Pfizer
Phase 2
100
Brno, Prague
2023-05-17
Recruiting
Takeda
Phase 3
240
Prague
2023-05-16
Recruiting
Novartis Pharmaceuticals
Phase 3
200
Plzen Bory, Prague
2023-05-11
Recruiting
Xenon Pharmaceuticals Inc.
Phase 3
360
Hradec Králové, Prague
2023-05-09
Active, closed
Gilead Sciences
Phase 3
654
Brno, Olomouc, Pardubice, Prague, Zlín
2023-05-08
Recruiting
Masaryk Memorial Cancer Institute
Not applicable
60
Brno
2023-05-02
Recruiting
The Institute of Molecular and Translational Medicine, Czech Republic
Observational
150
Ostrava
2023-05-02
Recruiting
University Hospital Ostrava
Not applicable
65
Ostrava
2023-05-02
Recruiting
General University Hospital, Prague
Not applicable
45
Prague
2023-05-01
Recruiting
Masaryk University
Not applicable
90
Brno
2023-05-01
Active, closed
IMPACT EU Post-Market Clinical Follow-Up Study
NCT05756751Left Ventricular Dysfunction
Abiomed Inc.
Not applicable
123
Prague
2023-04-27
By invitation
An Open-label Study of XEN1101 in Epilepsy
NCT05718817Focal Epilepsy, Tonic-Clonic Seizures
DrugAzetukalner
Xenon Pharmaceuticals Inc.
Phase 3
880
Prague
2023-04-25
Recruiting
Comprehensive Coronary Physiology in Patients With Angina With Nonobstructive Coronary Arteries - Czech Republic
NCT07103317ANOCA, ANOCA - Angina With Non-obstructive Coronary Arteries, MINOCA, Microvascular Dysfunction
University Hospital, Motol
Observational
1,000
Prague
2023-04-20
Active, closed
Karyopharm Therapeutics Inc
Phase 3
257
Brno, Ostrava, Prague
2023-04-18
Recruiting
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women
NCT04124120Heart Diseases, Coronary Artery Disease, Coronary Artery Bypass Grafting
Weill Medical College of Cornell University
Not applicable
2,300
Hradec Králové, New Town
2023-04-17
Active, closed
Czech Technical University in Prague
Observational
80
Prague
2023-04-17
Active, closed
BeOne Medicines
Phase 2/3
178
Olomouc, Prague
2023-04-17
Active, closed
TrEatment Approach in the Multimodal Era Registry
NCT05629052Chronic Thromboembolic Pulmonary Hypertension, CTEPH
International CTEPH Association
Observational
1,000
Prague
2023-04-12
Active, closed
Janssen Research & Development, LLC
Phase 3
20,284
Bílovec, Brandýs nad Labem, Brno, Broumov, Chomutov, Chrudim, České Budějovice, Jablonec nad Nisou
2023-04-11
By invitation
Sanofi
Phase 2
70
Brno, Ostrava, Prague
2023-04-05
Active, closed
Sanofi
Phase 2
118
Brno, Olomouc, Ostrava, Prague
2023-04-05
Active, closed
Comparative Efficacy, Safety, PK, and Immunogenicity Study
NCT05853354Osteoporosis, Postmenopausal
DrugDenosumab
Luye Pharma Group Ltd.
Phase 3
392
Brno, Prague
2023-04-05
Active, closed
Alfasigma S.p.A.
Phase 3
495
Prague, Brno, Ostrava, Pardubice, Uherské Hradiště, Zlín
2023-04-05
Active, closed
Bayer
Phase 3
985
Olomouc, Prague, Brno
2023-04-03
Active, closed
Sanofi
Phase 2
999
Nový Jičín, Ostrava, Prague
2023-04-03
Recruiting
Molecular Markes of Fibrosis of Endometriosis and Their Use in Predicting Disease Severity
NCT06020482Molecular Markers of Fibrosis of Single Types of Endometriosis and Their Use in Predicting Disease Severity
General University Hospital, Prague
Observational
120
Prague
2023-04-01
Recruiting
Charles University, Czech Republic
Observational
236
Prague
2023-04-01
Recruiting
University Hospital Ostrava
Not applicable
480
Liberec, Ostrava, Třinec, Olomouc, České Budějovice, Brno, Prague
2023-04-01
Recruiting
Charles University, Czech Republic
Observational
209
Ostrava, Pardubice, Prague, České Budějovice
2023-04-01
Recruiting
AstraZeneca
Phase 3
4,300
Hořovice, Pardubice, Prague, Pragues, Příbram
2023-03-31
Recruiting
Faculty Hospital Kralovske Vinohrady
Phase 4
100
Prague
2023-03-31
Active, closed
Janssen Research & Development, LLC
Phase 3
614
Brno, Olomouc, Ostrava - Poruba, Prague
2023-03-29
Active, closed
Novartis Pharmaceuticals
Phase 4
240
Prague, Uherské Hradiště
2023-03-28
Active, closed
Vladimíra Dostálová
Not applicable
316
Prague
2023-03-27
Active, closed
Boston Scientific Corporation
Observational
1,173
Brno, České Budějovice
2023-03-24
Recruiting
Brno University Hospital
Not applicable
90
Brno
2023-03-23
Active, closed
Janssen Research & Development, LLC
Phase 3
1,135
Brno, Hradec Králové, Liberec, Olomouc, Prague
2023-03-23
Active, closed
AbbVie
Phase 3
520
Brno, Prague, Nový Jičín, Ostrava
2023-03-15
Active, closed
Kardium Inc.
Not applicable
549
Prague
2023-03-09
By invitation
Eli Lilly and Company
Phase 3
338
Brno, Prague
2023-03-09
Active, closed
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
NCT05739383Primary Prevention of Atherosclerotic Cardiovascular Disease
DrugInclisiran
Novartis Pharmaceuticals
Phase 3
14,012
Louny, Ostrava, Ústí nad Labem, Přerov, Brandýs nad Labem, Brno, Chlumec nad Cidlinou, Český Krumlov
2023-03-09
Active, closed
PAPSY - Memory in Psychiatry
NCT05843357Cognitive Impairment
Charles University, Czech Republic
Observational
1,000
Prague
2023-03-08
Active, closed
Bristol-Myers Squibb
Phase 3
579
Prague, Hradec Králové, Olomouc, Ostrava Poruba
2023-03-06
Recruiting
Takeda
Phase 3
160
Prague
2023-03-06
Active, closed
Pfizer
Phase 3
624
Brno, Prague
2023-03-03
Active, closed
Novartis Pharmaceuticals
Phase 3
436
Brno, Prague, Uherské Hradiště
2023-03-02
Recruiting
Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation
NCT05797519Tricuspid Regurgitation, Tricuspid Valve Disease, Tricuspid Valvular Disorders
VDyne, Inc.
Not applicable
120
Třinec
2023-03-01
Active, closed
Ultragenyx Pharmaceutical Inc
Phase 3
69
Prague
2023-02-28
Active, closed
Novartis Pharmaceuticals
Phase 2
33
Prague
2023-02-28
Active, closed
AlgoTherapeutix
Phase 2
276
Prague, Teplice
2023-02-28
Active, closed
CardioFocus
Not applicable
200
Brno, Prague
2023-02-27
Active, closed
DAY101 vs. Standard of Care Chemotherapy in Pediatric Participants With Low-Grade Glioma Requiring First-Line Systemic Therapy (LOGGIC/FIREFLY-2)
NCT05566795Low-grade Glioma, Rapidly Accelerated Fibrosarcoma (RAF) Altered Glioma, Pediatric Low-grade Glioma
DrugsTovorafenib·Carboplatin
Day One Biopharmaceuticals, Inc.
Phase 3
418
Brno, Prague
2023-02-27
Active, closed
Janssen Research & Development, LLC
Phase 3
12,523
Brno, Jihlava, Olomouc, Ostrava - Vitkovice, Písek, Poruba, Prague
2023-02-15
Recruiting
Xenon Pharmaceuticals Inc.
Phase 3
160
Prague
2023-02-14
Active, closed
COMPASS Pathways
Phase 3
572
Klecany, Kutná Hora, Ostrava, Pilsen, Prague
2023-02-14
Recruiting
Novartis Pharmaceuticals
Phase 3
195
Prague
2023-02-10
Active, closed
Genmab
Phase 3
900
Brno, Hradec Králové, Ostrava, Prague
2023-02-08
Recruiting
MRD Monitoring in Colorectal Cancer Using ctDNA
NCT07895459Colorectal Neoplasms, Colorectal Cancer (Diagnosis), Minimal Residual Disease
Masaryk Memorial Cancer Institute
Not applicable
60
Brno
2023-02-07
Recruiting
Raman Spectroscopy in the Diagnosis of Extrahepatic Cholangiocarcinoma - a Pilot Study
NCT06964425Cholangiocarcinoma, Extrahepatic, Cholangiocarcinoma of the Extrahepatic Bile Duct, Cholangiocarcinoma, Perihilar, Diagnosis
University Hospital Olomouc
Not applicable
20
Olomouc
2023-02-04
Active, closed
Novartis Pharmaceuticals
Phase 3
226
Ostrava, Prague
2023-02-03
Active, closed
Novartis Pharmaceuticals
Phase 3
152
Brno, Prague
2023-02-02
Recruiting
JaxBio Ltd
Observational
3,000
Olomouc
2023-01-30
Active, closed
Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial
NCT05478304Ischemic Stroke, Systemic Embolism
AtriCure, Inc.
Not applicable
6,573
Brno
2023-01-25
Active, closed
Regeneron Pharmaceuticals
Phase 3
1,564
Brno, Hradec Králové, Ostrava
2023-01-16
Active, closed
ABTECT - Maintenance
NCT05535946Ulcerative Colitis
DrugObefazimod
Abivax S.A.
Phase 3
1,116
Brno, Hradec Králové, Olomouc, Ostrava, Prague, Slaný
2023-01-16
Active, closed
Bristol-Myers Squibb
Phase 3
513
Ostrava, Prague
2023-01-12
Active, closed
Daiichi Sankyo
Phase 3
1,233
Brno, Olomouc
2023-01-11
Rows per page Showing 501–1000 of 1513
Previous 1 2 3 4 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Czech investigative site. Derived from ClinicalTrials.gov. Retrieved 12 November 2026. https://priyalifescience.com/clinical-trials-czechia?page=2

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Czechia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 1,513 studies in total at the last sync on 11 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

How many clinical trials are recruiting in Czechia?

780 of the 1,513 studies in this register are recruiting new participants as of the 11 Nov 2026, 03:18 UTC sync. A further 62 have not yet opened recruitment, 611 are active but closed to new participants, and 60 are enrolling by invitation only. Eligibility for any study is decided by its study team.

This register, in your inbox every Friday

One email a week with how many trials are recruiting in Ireland, new EMA and FDA approvals and medicine shortages, built from the same public registers as this page.

Free. Unsubscribe from any email with one click. See our privacy policy.

→

Browse trials by condition

Multiple Myeloma (32) Obesity (28) Heart Failure (27) Ulcerative Colitis (24) Crohn's Disease (21) Breast Cancer (17) Chronic Lymphocytic Leukemia (17) Overweight (16) Atrial Fibrillation (16) Ovarian Cancer (15) Small Lymphocytic Lymphoma (13) Multiple Sclerosis (12) Carcinoma, Non-Small-Cell Lung (12) Atopic Dermatitis (12) Atrial Fibrillation (AF) (12)
→

Browse trials by site location

Prague (1080) Brno (610) Hradec Králové (323) Olomouc (313) Ostrava (282) Pilsen (117) Pardubice (92) České Budějovice (61) Zlín (47) Nový Jičín (45) Uherské Hradiště (38) Liberec (36) Náchod (33) Ústí nad Labem (33) Ostrava - Poruba (32)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.